SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending due to a significant intraday price drop, sparking discussions about potential causes, including sector-wide AI concerns and possible manufactured short attacks. Community members are debating the long-term fundamentals versus short-term volatility, with some calling for news from leadership to reassure investors. The stock's high short interest and previous volatility are also fueling speculation about potential bounces and future direction.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to a potential short squeeze, with community members actively discussing removing stop losses and setting high limit orders. The stock's volatile price action and high trading volume are fueling speculation of a significant run, drawing comparisons to other recent low-float movers in the robotics sector.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to excitement surrounding the CEO's webinar presentation, with investors anticipating positive news and a potential short squeeze. The community is actively discussing the webinar's potential impact and debating whether a significant upward move is imminent, while some caution against potential short attacks after the webinar concludes. Some investors are drawing comparisons to other trending tickers, while others are focused on the longer-term potential of RADX's theranostic technology.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

Artiva Biotherapeutics ($ARTV) is trending following news of FDA Fast Track designation for its AlloNK therapy in refractory rheumatoid arthritis, with Wedbush raising its price target significantly. The community is actively discussing the potential for a squeeze, with some cautioning about a possible offering. Bullish sentiment is fueled by the company's cash position and upcoming data releases.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation surrounding potential cannabis rescheduling following reports of a possible executive order. Community discussions revolve around the timing and impact of the news, with many anticipating significant movement in the cannabis sector. Some traders are expressing concerns about a potential "pump and dump" scenario if the news does not materialize as expected.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings ($CLIK) is trending as traders discuss its low float and potential for a significant move, drawing comparisons to other stocks with similar setups. Community members are awaiting news or updates from the company, especially regarding acquisitions and crypto treasury plans, which they believe could act as a catalyst. Some traders are also highlighting the stock's high short borrow rate, suggesting a possible short squeeze scenario.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is trending as the community discusses its potential for a short squeeze and positive momentum, with some pointing to the company's fundamentals. There's also speculation around a potential inclusion in the S&P 500 index, and commentary on its valuation relative to peers in the social media and AI spaces.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is surging, fueled by discussions around its autonomous driving capabilities and the potential for Robotaxi services following a clip circulating of a Tesla driving without a safety monitor. The community is debating whether the current valuation is justified, with some pointing to high P/E ratios and others anticipating significant future growth driven by AI and energy initiatives, while there is sentiment the Robotaxi is simply hype to pump the stock.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending as investors react to a recent analyst downgrade and assess the company's potential in a shifting economic landscape. While some community members see the dip as a buying opportunity, others question the valuation and future growth prospects amidst rising competition. Discussions also revolve around the upcoming earnings report and the possibility of a special dividend or stock split.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Despite strong earnings and analyst upgrades, Broadcom ($AVGO) is trending down, sparking discussions about potential overvaluation and market manipulation. The community is debating whether to buy the dip or if further declines are ahead, with some citing concerns about AI growth sustainability and negative outlooks. Others point to the company's strong fundamentals and potential for a rebound, viewing the current price as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company highlighted an 80% recurrence rate reduction in the open-label non-HLA-A*02 arm of the Phase III clinical trial.&nbsp;</li><li>The company noted that the latest observation trended similarly to its Phase IIb trial results and hazard ratio.</li></ul>Greenwich LifeSciences, Inc.’s (GLSI) shares soared in premarket trading on Monday after the company announced positive results from its phase III clinical trial, FLAMINGO-01, evaluating an immunotherapy to prevent breast cancer recurrences.Greenwich highlighted about an 80% recurrence rate reduction in the open-label non-HLA-A*02 arm of the Phase III clinical trial.Shares of <a href="https://stocktwits.com/symbol/GLSI">GLSI</a> were up over 86% premarket at the time of writing.<h2 class="st-heading-2">Trial Details</h2>The company noted that the latest observation trended similarly to its Phase IIb trial results and hazard ratio, where the patients were treated, and breast cancer recurrences were reduced up to 80% compared to a 20-50% reduction in recurrence rate by other approved products.“Despite these being preliminary results that will mature and can change with time, seeing a reduction in expected recurrence rates that is trending towards a low HR of 0.2, which represents an 80% reduction in recurrence rate, is very encouraging and which is why along with the similarly promising safety and immune response data to date, we will seek to continue to treat non-HLA-A*02 patients in a placebo controlled manner in the study," said CEO Snehal Patel.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, GLSI was the second-most trending stock on Monday morning. The retail sentiment around GLSI continued to trend in the ‘extremely bullish’ territory compared to ‘bullish’ a month ago, while message volume has remained ‘extremely high’ at the time of writing.<figure class="image"><img style="aspect-ratio:1279/145;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_15_at_5_07_16_PM_png_76f022ac17.webp" alt="Retail sentiment for GLSI at the time of writing was 'extremely bullish' and message volume was 'extremely high'." width="1279" height="145"></figure>One Stocktwits user said they would be watching the stock all day, indicating their bullish stance on the company.<stembedurl>https://stocktwits.com/Rolltide2020/message/639156747</stembedurl>Shares of GLSI are down over 16% over the last year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Mammogram imagery, regular mammogram on the left, and contrast enhanced mammogram on the right, on Thursday, Sept. 26, 2024 in Houston. (Brett Coomer/Houston Chronicle via Getty Images)

Why Is GLSI Stock Rising Today?

Greenwich LifeSciences shares surged following the company’s announcement of positive results from its phase III clinical trial, FLAMINGO-01. 

Why Is GLSI Stock Rising Today? 

Equity

Greenwich LifeSciences shares surged following the company’s announcement of positive results from its phase III clinical trial, FLAMINGO-01. 


Noble Financial Issues Pessimistic Outlook for GLSI Earnings

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Equities research analysts at Noble Financial decreased their FY2025 EPS estimates for Greenwich LifeSciences in a research note issued on...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases $38,502.00 in Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 4,600 shares of Greenwich LifeSciences stock in a transaction that occurred on Tuesday, November 25th. The stock...

Greenwich LifeSciences (NASDAQ:GLSI) Releases Earnings Results, Meets Expectations

Greenwich LifeSciences (NASDAQ:GLSI - Get Free Report) released its earnings results on Friday. The company reported ($0.30) EPS for the quarter, hitting the consensus estimate of ($0.30...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases 10,600 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 10,600 shares of the stock in a transaction on Friday, November 7th. The shares were acquired at an average...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Buys $89,358.00 in Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 10,600 shares of the company's stock in a transaction on Friday, November 7th. The shares were purchased at an...

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.34	--	--	N/A
Q3 '25	-$0.36	--	--	N/A
Q2 '25	-$0.30	-$0.30	--	EXPECTED
Q1 '25	-$0.24	--	--	N/A
Q4 '24	-$0.21	--	--	N/A

GLSI
Greenwich LifeSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest GLSI News

GLSIGreenwich LifeSciences Inc